Importer of Controlled Substances Registration, 45523 [2019-18687]
Download as PDF
<![CDATA[
45523
Federal Register / Vol. 84, No. 168 / Thursday, August 29, 2019 / Notices
Controlled substance
Drug code
Thiafentanil ......................................................................................................................................................................
Racemethorphan .............................................................................................................................................................
Alfentanil ..........................................................................................................................................................................
Remifentanil .....................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
Carfentanil .......................................................................................................................................................................
Tapentadol .......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
The company plans to manufacture
small quantities of the listed controlled
substances to make reference standards
which will be distributed to its
customers.
Drug Enforcement Administration
[Docket No. DEA–392]
ACTION:
[FR Doc. 2019–18681 Filed 8–28–19; 8:45 am]
Notice of registration.
The registrants listed below
have applied for ad been granted
registration by the Drug Enforcement
SUMMARY:
BILLING CODE 4410–09–P
The
companies listed below applied to be
registered as an importers of various
basic classes of schedule I and II
controlled substances. Information on
previously published notices is listed in
the table below. No comments or
objections were submitted and no
requests for a hearing were submitted
for these notices.
SUPPLEMENTARY INFORMATION:
Companies
khammond on DSKBBV9HB2PROD with NOTICES
II
II
II
II
II
II
II
II
Administration (DEA) as importers of
schedule I and II controlled substances.
DEPARTMENT OF JUSTICE
Importer of Controlled Substances
Registration
Dated: August 9, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
9729
9732
9737
9739
9740
9743
9780
9801
Schedule
FR docket
Mylan Pharmaceuticals Inc ..............................................................................................................
Rhodes Technologies ......................................................................................................................
S & B Pharma, Inc ...........................................................................................................................
Wildlife Laboratories, Inc .................................................................................................................
84
84
84
84
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable various basic classes of
schedule I and II controlled substances
is consistent with the public interest
and with United States obligations
under international treaties,
conventions, or protocols in effect on
May 1, 1971. The DEA investigated each
of the company’s maintenance of
effective controls against diversion by
inspecting and testing each company’s
physical security systems, verifying
each company’s compliance with state
and local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule II controlled substances to the
above listed companies.
July 1st 2019 through July 31st 2019.
Post-initial determinations are issued
after a petition has been certified or
denied. A post-initial determination
may revise a certification, or modify or
affirm a negative determination.
Dated: August 16, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
[FR Doc. 2019–18687 Filed 8–28–19; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
17:00 Aug 28, 2019
Jkt 247001
DEPARTMENT OF LABOR
Employment and Training
Administration
Post-Initial Determinations Regarding
Eligibility To Apply for Trade
Adjustment Assistance
In accordance with Sections 223 and
284 (19 U.S.C. 2273 and 2395) of the
Trade Act of 1974 (19 U.S.C. 2271, et
seq.) (‘‘Act’’), as amended, the
Department of Labor herein presents
Notice of Affirmative Determinations
Regarding Application for
Reconsideration, summaries of Negative
Determinations Regarding Applications
for Reconsideration, summaries of
Revised Certifications of Eligibility,
summaries of Revised Determinations
(after Affirmative Determination
Regarding Application for
Reconsideration), summaries of
Negative Determinations (after
Affirmative Determination Regarding
Application for Reconsideration),
summaries of Revised Determinations
(on remand from the Court of
International Trade), and summaries of
Negative Determinations (on remand
from the Court of International Trade)
regarding eligibility to apply for trade
adjustment assistance under Chapter 2
of the Act (‘‘TAA’’) for workers by (TA–
W) number issued during the period of
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
FR
FR
FR
FR
18321
21807
21813
21809
.............
.............
.............
.............
Published
April 30, 2019.
May 15, 2019.
May 15, 2019.
May 15, 2019.
Notice of Revised Certifications of
Eligibility
Revised certifications of eligibility
have been issued with respect to cases
where affirmative determinations and
certificates of eligibility were issued
initially, but a minor error was
discovered after the certification was
issued. The revised certifications are
issued pursuant to the Secretary’s
authority under section 223 of the Act
and 29 CFR 90.16. Revised
Certifications of Eligibility are final
determinations for purposes of judicial
review pursuant to section 284 of the
Act (19 U.S.C. 2395) and 29 CFR
90.19(a).
Summary of Statutory Requirement
(This Notice primarily follows the
language of the Trade Act. In some
places however, changes such as the
inclusion of subheadings, a
reorganization of language, or ‘‘and,’’
‘‘or,’’ or other words are added for
clarification.)
E:\FR\FM\29AUN1.SGM
29AUN1
]]>Agencies
[Federal Register Volume 84, Number 168 (Thursday, August 29, 2019)]
[Notices]
[Page 45523]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-18687]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: The registrants listed below have applied for ad been granted
registration by the Drug Enforcement Administration (DEA) as importers
of schedule I and II controlled substances.
SUPPLEMENTARY INFORMATION: The companies listed below applied to be
registered as an importers of various basic classes of schedule I and
II controlled substances. Information on previously published notices
is listed in the table below. No comments or objections were submitted
and no requests for a hearing were submitted for these notices.
----------------------------------------------------------------------------------------------------------------
Companies FR docket Published
----------------------------------------------------------------------------------------------------------------
Mylan Pharmaceuticals Inc..................... 84 FR 18321.................... April 30, 2019.
Rhodes Technologies........................... 84 FR 21807.................... May 15, 2019.
S & B Pharma, Inc............................. 84 FR 21813.................... May 15, 2019.
Wildlife Laboratories, Inc.................... 84 FR 21809.................... May 15, 2019.
----------------------------------------------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of the listed registrants
to import the applicable various basic classes of schedule I and II
controlled substances is consistent with the public interest and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. The DEA investigated each of the
company's maintenance of effective controls against diversion by
inspecting and testing each company's physical security systems,
verifying each company's compliance with state and local laws, and
reviewing each company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule II controlled substances to the above listed
companies.
Dated: August 16, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
[FR Doc. 2019-18687 Filed 8-28-19; 8:45 am]
BILLING CODE 4410-09-P
